Study Objectives: To determine whether arousals that terminate obstructive events in obstructive sleep apnea (OSA) (1) induce hypocapnia and (2) subsequently reduce genioglossus muscle activity following the return to sleep. Methods: Thirty-one untreated patients with OSA slept instrumented with sleep staging electrodes, nasal mask and pneumotachograph, end-tidal CO 2 monitoring, and intramuscular genioglossus electrodes. End-tidal CO 2 was monitored, and respiratory arousals were assigned an end-arousal CO 2 change value (P ET CO 2 on the last arousal breath minus each individual's wakefulness P ET CO 2 ). This change value, in conjunction with the normal sleep related increase in P ET CO 2 , was used to determine whether arousals induced hypocapnia and whether the end-arousal CO 2 change was associated with genioglossus muscle activity on the breaths following the return to sleep. Results: Twenty-four participants provided 1137 usable arousals. Mean ± SD end-arousal CO 2 change was −0.2 ± 2.4 mm Hg (below wakefulness) indicating hypocapnia typically developed during arousal. Following the return to sleep, genioglossus muscle activity did not fall below prearousal levels and was elevated for the first two breaths. End-arousal CO 2 change and genioglossus muscle activity were negatively associated such that a 1 mm Hg decrease in end-arousal CO 2 was associated with an ~2% increase in peak and tonic genioglossus muscle activity on the breaths following the return to sleep. Conclusions: Arousal-induced hypocapnia did not result in reduced dilator muscle activity following return to sleep, and thus hypocapnia may not contribute to further obstructions via this mechanism. Elevated dilator muscle activity postarousal is likely driven by non-CO 2 -related stimuli.
INTRODUCTION
Two-thirds of obstructive events terminate with an arousal from sleep. 1, 2 Obstructions that terminate with arousal have a larger ventilatory response than obstructions that terminate without arousal. 1, 3 It is believed that the hypocapnia associated with an arousal promotes further obstruction by reducing upper airway dilator muscle activity following the return to sleep. 1, [4] [5] [6] This consequence of arousal in patients with obstructive sleep apnea (OSA) is widely accepted, despite little supporting empirical evidence.
The concept that arousal facilitates obstruction arose from studies that induced hypocapnia during stable sleep and demonstrated increased airway resistance, flow limitation, and obstruction for individuals with mild anatomical compromise (snorers). [7] [8] [9] One study found obstruction occurred only when genioglossus muscle activity fell below a critical ratio with respect to diaphragm muscle activity. 9 From this, it was inferred that hypocapnia reduces dilator muscle activity and promotes collapse and that arousal-induced hypocapnia would have similar effects.
Contrary to studies during stable sleep, studies of arousal in healthy individuals and patients with OSA on continuous positive airway pressure (CPAP) have found no evidence for reduced dilator muscle activity postarousal. 3, [10] [11] [12] [13] [14] [15] Rather, dilator muscle activity was shown to rapidly increase at arousal and then slowly decay back toward prearousal levels, regardless of whether arousal was spontaneous or induced by auditory or respiratory stimuli. One study reported that dilator muscle activity was no different following obstructions that terminated with or without arousal. 3 That arousal leads to further obstruction also lacks experimental support. Following arousal, ventilation falls back to, but not markedly below, prearousal levels in healthy individuals and patients with OSA. 3, 10, [12] [13] [14] [15] [16] [17] [18] Similarly, resistance is no worse following arousal and is sometimes improved compared to no arousal or arousal with a smaller ventilatory response. 10, 12, 14, [17] [18] [19] Inconsistences between the hypothesized adverse effects of arousal and prior research may be due to methodological issues. For example, prior studies have not assessed untreated patients with OSA to whom the arousal hypothesis is proposed to apply, and only a few studies measured P ET CO 2 . Alternatively, the arousal hypothesis may be incorrect. The ventilatory response magnitude may be appropriate for the preceding respiratory disturbance and consequent hypercapnia such that hypocapnia does not develop. 3 Or, the dilator muscle activation elicited at obstructive event termination may persist following the return to sleep irrespective of hypocapnia. Persistence of activation beyond stimulus removal is referred to as after-discharge and has been demonstrated for the genioglossus muscle during
Statement of Significance
This study is the first to demonstrate that hypocapnia is induced by arousals that terminate naturally occurring obstructive events in OSA. Pronounced hypocapnia during arousal was associated with elevated dilator muscle activity following the return to sleep. This suggests that postarousal genioglossus activity is not strongly influenced by CO 2 . This finding is contrary to the concept that arousal-induced hypocapnia predisposes to further obstructions via reduced upper airway dilator muscle activity following the return to sleep. Future work should examine the mechanism which results in elevated dilator muscle activity following the return to sleep, as it may offer a potential treatment target for OSA.
wakefulness and sleep in both healthy individuals and patients with OSA. 15, 20 We aimed to investigate these possibilities by studying untreated patients with OSA to determine (1) whether hypocapnia is induced by arousal associated with respiratory events; (2) whether genioglossus activity and ventilation are reduced on return to sleep following arousal associated with respiratory events; and (3) whether genioglossus activity and ventilation following the return to sleep are influenced by the level of CO 2 during arousal associated with respiratory events.
METHODS

Participants
Thirty-one patients with mild to severe OSA (9 female) aged 20-65 years were recruited from two sites: 15 were recruited from the Brigham and Women's Hospital (BWH) and 16 from the Institute for Breathing and Sleep, Austin Hospital (IBAS). All participants provided written informed consent, and the study was approved by ethics review committees at both sites (BWH: 2004-P-001345; IBAS: 1238360.3).
Participants were free of neurological, cardiorespiratory, and sleep disorders except for OSA. They were also nonsmokers and not taking medications known to affect sleep, breathing, or muscle activity.
Data from BWH were used in a prior publication assessing different hypotheses. 21 Data from IBAS were obtained from the baseline/placebo condition in a clinical trial assessing acupuncture effects in OSA (see online supplement). Results from this clinical trial have not yet been published.
Instrumentation and Measurement
Participants were instrumented with electroencephalogram (EEG; BWH: C3-A1 and Oz-A2; IBAS: C4-A1, O2-A1), left and right electrooculography (EOG), and mentalis electromyogram (EMG; EMG MEN ). EMG MEN was used instead of the standard submental EMG placement because the latter is too close to the insertion location of the genioglossus electrodes. Genioglossus muscle activity (EMG GG ) was recorded with fine-wire intramuscular electrodes inserted perorally at BWH (single pair of unipolar teflon coated 30 gauge fine-wire electrodes referenced to each other) and percutaneously at IBAS (two pairs of 44 gauge fine-wire needle electrodes; 000-318-130, Chalgren Enterprises, Inc, Gilroy, CA with 5-mm bare) to provide a bipolar recording of muscle activity. For further details regarding wire electrode insertion see online supplement. Participants were fitted with a leak-proof nasal mask or face mask if they had difficulty breathing through their nose. A pneumotachograph (BWH and IBAS: Model 3700A; Hans Rudolph Inc, Kanas City, MO) connected to a differential pressure transducer (BWH and IBAS: Model-CD223; Validyne, Northridge, CA) recorded flow. A pressure-tipped catheter (BWH and IBAS: MPC-500; Millar, Houston, TX) placed through a decongested (BWH: 0.05% Oxymetazoline, HCI) and anesthetized nostril (BWH: 4% Lidocaine HCI; IBAS: AnGel with 1-2mg of Amethocaine) recorded epiglottic pressure (P EPI ). The catheter was advanced until it was near the epiglottis (approximately 1.5-2 cm below the tongue base) as confirmed by visual inspection through the mouth. P ET CO 2 
Protocol
Participants arrived at the laboratory approximately 2 hours earlier than their regular bedtime. After being fitted with the equipment listed earlier, they participated in individual calibration procedures. To assess signal integrity of the EEG, EOG, and EMG MEN , each participant was instructed to close their eyes, look left-right and up-down, as well as make a chewing motion with their jaw. To ensure correct functioning of the EMG GG electrodes and to obtain maximal EMG GG values, the participants were instructed to swallow and protrude their tongue against their teeth as hard as possible 3 times each. Quiet wakefulness was recorded for baseline measures. Participants were instructed to sleep supine, as position had to be controlled, and the supine position was considered easiest to maintain with all the physiological recording equipment attached. Participants were left to sleep undisturbed without OSA treatment for the night.
Data Analysis
A trained sleep technician scored sleep and arousals according to the AASM 2007 scoring manual using EEG, EOG, and EMG MEN information while blinded to the other signals. 22 Respiratory events were then scored using the 2012 AASM updated criteria. 23 Hypopneas were scored as a ≥30% reduction in flow for at least 10 seconds, with a 3% desaturation or an arousal. Apneas were scored as a ≥90% reduction in flow for at least 10 seconds. In addition, respiratory event-related arousals (RERAs) were also scored, as RERAs are respiratory events that do not meet the criteria for hypopnea but still result in arousal. RERAs were scored when there was a flattening of the inspiratory flow trace for at least 10 seconds, accompanied by increasing respiratory effort (observed on P EPI ) that resulted in an arousal.
The identified arousals were included in the analysis providing they satisfied the following criteria: (1) The arousal occurred during nonrapid eye movement (NREM) stage 2 or slow wave sleep. (2) Arousal onset began within 5 seconds of a preceding respiratory event (hypopnea, apnea, and RERA). (3) The participant was supine during the arousal. (4) The P ET CO 2 on the last breath of the arousal had a clear plateau.
Data for the muscle and respiratory variables were analyzed on a breath-by-breath basis relative to both the onset of arousal and sleep as determined by EEG. If arousal occurred during inspiration that particular breath was labeled the first breath of arousal. If arousal occurred during expiration the following breath was labeled the first breath of arousal. If, following arousal, sleep onset occurred during the first half of a breath that breath was labeled the first breath of sleep onset. If sleep onset occurred during the second half of a breath the following breath was labeled the first breath of sleep onset.
The EMG GG signal was rectified, smoothed, and moving time averaged with a time constant of 100 ms (BWH: Nihon Kohden, Foothill Ranch, CA; IBAS: Spike 2, CED Cambridge, UK). The EMG GG signal was then converted to a percentage of maximum using the greatest level of activity attained during the calibration maneuvers (100%) and electrical zero (0%). Next, due to high variability in the values obtained during wakefulness between participants, the percentage of maximum EMG GG values for prearousal sleep, arousal, and postarousal sleep breaths were scaled as a percentage of each participant's mean peak and tonic activity during initial wakefulness. Peak activity was defined as the highest activation during the inspiratory phase. Tonic activity was defined as the lowest activation during the expiratory phase.
For each arousal, custom-written software was used to extract the respiratory signals on each of the five sleep breaths prior to arousal, each of the breaths during the arousal, and each of the five breaths following the return to sleep postarousal (see Figure  1 ). The variables extracted were minute ventilation (V̇I), tidal volume (V T ), frequency of breathing (fb), P ET CO 2 , nadir P EPI , and peak and tonic EMG GG . If any of these recordings had artifact or noise, the data were discarded for the affected breaths. Similarly, if a swallow occurred and EMG GG activity was visibly affected, the EMG GG data were discarded for the affected breath. When a second arousal occurred before the conclusion of the five "sleep" breaths following the first arousal, data from the second arousal were discarded, but the sleep breaths prior to the second arousal were included in the analyses.
To determine whether participants were hypocapnic on the last breath of arousal, an end-arousal CO 2 change value (endarousal ∆CO 2 ) was computed. The end-arousal ∆CO 2 was the P ET CO 2 at the last breath of arousal minus the individual participant's mean P ET CO 2 value during wakefulness. For example, if a participant had a P ET CO 2 of 37.1 mm Hg on the last breath of arousal and their wakefulness baseline P ET CO 2 was 38.2, the ∆CO 2 change for that particular arousal was −1.1 mm Hg. Thus, the end-arousal ∆CO 2 for a given arousal within an individual participant could be any value above, equal to, or below the wakefulness value. Wakefulness baseline P ET CO 2 was used as a reference point because often normocapnic P ET CO 2 cannot be obtained during sleep in patients with OSA due to repetitive cycling of obstructive events. However, studies of healthy individuals have shown that the NREM CO 2 set point is usually 2-4 mm Hg above wakefulness CO 2.
24-26 Therefore end-arousal ∆CO 2 values below this range (2-4 mm Hg above wakefulness P ET CO 2 ) were considered to represent hypocapnia. This approach was validated by assessing the participants who were able to achieve stable breathing during NREM sleep Figure 1 -Breaths analyzed relative to arousal. Breaths 1-5 are prearousal breaths. Breath -1 is the last breath of arousal. Breaths S1-S5 are the first five breaths following the return to sleep. Variables extracted for all breaths are flow (L/min), peak and tonic genioglossus muscle activity (EMG GG ), and nadir epiglottic pressure (nadir P EPI ). Partial end-tidal CO 2 (P ET CO 2 ) was extracted only on the last breath of arousal. Note the number of arousal breaths is variable, and in this particular example there were only two.
(n = 13), and comparing their wakefulness P ET CO 2 and their NREM sleep P ET CO 2 during stable breathing (see supplement for further details). Paired Students t-test for the 13 participants revealed that the mean ± SD wakefulness (39.9 ± 3.1 mm Hg) and sleep (42.9 ± 4.1 mm Hg) P ET CO 2 values were significantly different (p = .001). This difference of 3.0 ± 2.3 mm Hg was consistent with the range estimated by adding 2-4 mm Hg above the wakefulness value.
Statistical Analysis
Effect of arousal on peak EMG GG , tonic EMG GG , nadir P EPI , and V̇I Mixed-model analysis with pairwise comparisons determined whether muscle activity (peak and tonic EMG GG ) and respiratory variables (V̇I & nadir P EPI ) on the last breath of arousal and each of the five breaths following the return to sleep were significantly different from the average of the prearousal breaths (average of the fifth, fourth, third, and second breaths leading to arousal). The last breath prior to arousal was not included in the prearousal average, as defining the exact start of an arousal can be difficult and in many instances airway opening occurs just before arousal. 1 The repeated measure variable "breath" was entered as a fixed factor in the mixed models. Breath comprised 7 levels (prearousal average, last arousal breath, first sleep breath, second sleep breath, third sleep breath, fourth sleep breath, and fifth sleep breath). The interaction of variable "participant" and "arousal trial number" was entered as a random factor to control for differences between individuals and between arousal trials within individuals. Significance was set at p < .05.
Linear modeling determined whether end-arousal ∆CO 2 was associated with the respiratory and muscle activity on the last breath of arousal and each of the first five breaths following the return to sleep. "End-arousal ∆CO 2 " was entered as a covariate. "Participant ID" was entered as fixed factor to control for individual participant effects. The muscle variable ("peak EMG GG " or "tonic EMG GG ") or respiratory variable ("V̇I" or "nadir P EPI ") of interest was entered as the dependent variable. Separate models were constructed for each variable of interest for the last breath of arousal and each of the breaths following the return to sleep. The intercept, slope, and individual participant factors derived from the linear model were used to predict peak and tonic EMG GG , nadir P EPI , and V̇I for a given end-arousal ∆CO 2 within an "average participant." Significance was set at p < .05.
Variables were transformed to meet statistical assumptions. Outliers that did not fit the overall data pattern were identified based on visual examination of the residual plots as recommended by Kay. 27 All 28 analyses were performed with both the outliers removed and the outliers included. The number of outliers removed was less than 1.2% in each analysis (see online supplement for further details). The results did not differ when outliers were included or excluded, with the exception of one analysis (Mixed models-Tonic EMG GG analysis). In this analysis, the breaths following the return to sleep that were statistically significant were breaths 1 and 2 when outliers were excluded and breaths 1, 2, 3, and 5 when outliers were included. Due to near-identical results (see online supplement), the data are presented with the outliers removed. Analyses were conducted using IBM SPSS version 19 (Armonk, NY). Table 1 . Data from seven participants could not be included, as three could not sleep supine, one had respiratory events only during rapid eye movement, one had only central respiratory events, one had dislodgement of EMG GG wires, and another had EEG signals too poor to accurately identify arousal start and stop times.
RESULTS
Mean wakefulness time analysed per participant was 4.8 mins (range = 1.1-9.8 mins). Respiratory and muscle activity during wakefulness for the participants included in the analysis are shown in Table 2 . The 24 participants yielded 1137 arousals usable for analysis. The median usable arousals was 43 (range = 16-104). Hypopneas were the most common respiratory event that proceeded the arousals analyzed (68%), followed by apneas (27%), and then RERAs (5%). 2 A Student's paired t-test was used to compare the mean ± SD participant wakefulness P ET CO 2 39.4 ± 3.3mm Hg to the mean participant end-arousal P ET CO 2 39.1 ± 3.2 mm Hg. The difference which corresponded to an end-arousal ∆CO 2 of Figure 2 . For 19 participants, the mean end-arousal ∆CO 2 was below the NREM CO 2 set point range (2-4 mm Hg above wakefulness CO 2 ) .
End-Arousal ∆CO
−0.2 ± 2.4 mm Hg (below wakefulness) was not statistically significant. The mean end-arousal ∆CO 2 for each participant is shown in
24-26
Effect of Arousal on Peak EMG GG , Tonic EMG GG , V̇I, and Nadir P EPI Independent of End-Arousal ∆CO 2 Peak EMG GG , tonic EMG GG , and nadir P EPI (first converted to positive by multiplying by -1) were log 10 transformed to satisfy statistical assumptions of mixed-and linear model analyses. Transformed values were back-transformed to aid interpretation of results. V̇I did not require transformation.
Mixed-model analyses demonstrated that log 10 peak EMG GG , and log 10 tonic EMG GG were significantly elevated above the prearousal average on the last breath of arousal and the first two breaths following return to sleep (See figure 3) . V̇I and log 10 nadir P EPI were significantly elevated above the prearousal average for the last breath of arousal and each of the five breaths following the return to sleep (See figure 3) . Neither the muscle nor respiratory variables fell below prearousal levels on any of the five breaths following the return to sleep.
Association Between End-Arousal ∆CO 2 and EMG GG Following the Return to Sleep
The association between the end-arousal ∆CO 2 and the untransformed peak and tonic EMG GG values for the first breath following the return to sleep is shown in Figure 4A and B, respectively.
Linear modeling with adjusted individual differences demonstrated a statistically significant negative association between end-arousal ∆CO 2 and log 10 peak EMG GG for the last breath of arousal and each of the five breaths following return to sleep, except breath 4 (see table 3 ). Results were similar for log 10 tonic EMG GG . As shown in Table 3 , when log 10 EMG GG values were back-transformed, a 1-mm Hg decrease in the endarousal ∆CO 2 corresponded to peak EMG GG increase of ~3% (percentage change) on the last breath of arousal and ~2% on each of the breaths following return to sleep. Similarly, a 1-mm Hg decrease in end-arousal ∆CO 2 corresponded to an increase in tonic EMG GG of ~2% (percentage change) on both the last breath of arousal and each of the breaths following the return to sleep. The average r 2 values for the peak and tonic log 10 EMG GG linear models were both 0. 6 . Linear models that demonstrate the association between end-arousal ∆CO 2 and the back-transformed peak and tonic EMG GG are shown in Figure 5 .
Association Between End-Arousal ∆CO 2 and Respiratory Variables Following the Return to Sleep
Minute Ventilation
The association between the end-arousal ∆CO 2 and the V̇I on the first breath following the return to sleep is shown in Figure 4C . Linear modeling demonstrated that for the last breath of arousal, and each of the breaths following the return to sleep (except breath 2), there was a significant linear association between end-arousal ∆CO 2 and V̇I (p < .001). The change in V̇I for a 1-mm Hg decrease in end-arousal ∆CO 2 is shown in Table 4 . There was a negative linear association between the end-arousal ∆CO 2 and V̇I on both the last breath of arousal and the first breath following the return to sleep such that when endarousal ∆CO 2 was negative (below wakefulness) ventilation was increased. In contrast, breaths 3, 4, and 5 following the return to sleep showed significant positive linear associations such that when end-arousal ∆CO 2 was negative ventilation was decreased. The average r 2 value for the V̇I linear models was 0.5. Linear models that demonstrate the association between endarousal ∆CO 2 and V̇I are shown in Figure 5C .
Pressure at the epiglottis
The association between end-arousal ∆CO 2 and untransformed nadir P EPI for the first breath following the return to sleep is shown in Figure 4D . Linear modeling showed no association between end-arousal ∆CO 2 and log 10 nadir P EPI on the last breath of arousal (p = .54) and the last breath of return to sleep (p = .97; see Table 4 ). However, there was a significant negative association between end-arousal ∆CO 2 and log 10 nadir P EPI on the first, second, third, and fourth breaths following return to sleep. When log 10 nadir P EPI was back-transformed, a decrease in end-arousal ∆CO 2 of 1-mm Hg corresponded to an increase in P EPI of ~.26 cmH 2 O on the first, second, third, and fourth breaths following the return to sleep. Therefore, the more negative the end-arousal ∆CO 2 , the less negative pressure was at the epiglottis. The average r 2 value for the log 10 nadir P EPI linear models was 0.5. Linear models that demonstrate the association between end-arousal ∆CO 2 and back-transformed nadir P EPI are shown in Figure 5D .
DISCUSSION
Are Patients With OSA Hypocapnic Following Arousal Terminating Obstruction?
This is the first study to assess CO 2 changes following arousal in untreated patients with OSA. Consistent with the hypothesized adverse effects of arousal, patients with OSA were hypocapnic by the end of the arousals that terminated obstructive events. While the exact severity of hypocapnia was unknown because sleeping normocapnic values could not be obtained in all participants, 59% of arousals had an end-arousal ∆CO 2 that was below wakefulness eucapnia and a clear majority were below the estimated sleep eucapnia. This finding is consistent with studies that have demonstrated hypocapnia following spontaneous and auditory arousal in healthy individuals and patients with OSA on CPAP. 10, 12, 18, 19 The magnitude of the CO 2 reduction due to arousal was consistent with a study that assessed arousal and CO 2 in tracheostomized patients with OSA. 28 In that study, the tracheostomy was blocked to elicit obstruction and relieved upon arousal. On the last breath of hyperpnea, P ET CO 2 was reduced by ~3 mm Hg relative to sleeping eucapnia (breathing through the tracheostomy tube). As the patients in the current study had an end-arousal ∆CO 2 of −0.2 mm Hg and sleeping normocapnia is ~2-4 mm Hg above wakefulness normocapnia, [24] [25] [26] it is likely they experienced a similar magnitude CO 2 reduction. This interpretation was supported by a subanalysis of patients with OSA who were able to achieve stable breathing during sleep (n = 13). This analysis revealed that NREM sleep was indeed associated with a 3-mm Hg increase in CO 2 compared to wakefulness. The findings of the current and prior studies are discordant with our recent proposal that hyperpnea magnitude may not be excessive but rather necessary to restore eucapnia following obstruction. 
The Effect of Arousal on Genioglossus Activity and Ventilation Following the Return to Sleep
Contrary to the hypothesized negative effects of arousal, neither peak nor tonic genioglossus activity fell below prearousal occluded levels following the return to sleep. This was despite hypocapnia and reduced negative pressures relative to the prearousal occluded phase. Rather, genioglossus muscle activity was elevated above prearousal occlusion levels for the first several breaths following the resumption of sleep. This finding is consistent with prior studies of arousal in healthy individuals and patients with OSA on CPAP. 3, [10] [11] [12] [13] [14] Upper airway patency was also improved following obstructive events that terminated with arousal. Following the return to sleep, the untreated patients with OSA experienced increased ventilation and reduced epiglottic pressure relative to the prearousal occluded breaths. Prior studies have also demonstrated and e represents a significant association between the change in EMG GG and end-arousal ∆CO 2 at p < .001, p < .01, and p < .05, respectively.
Figure 5-Modeled change in peak and tonic genioglossus muscle activity (EMG GG = A and B, respectively), minute ventilation (V̇I = C), and nadir epiglottic pressure (nadir P EPI = D) for a given end-arousal CO 2 change (∆CO 2 = P ET CO 2 at the last breath of arousal minus the individual participant's mean P ET CO 2 value during wakefulness) for the last breath of arousal and the five breaths following return to sleep. Models are based on the average response of all participants in the sample. ^,*, and # denotes significant association between variable and end-arousal ∆CO 2 at p < .001, p < .01 p < .05, respectively. Note peak EMG GG , tonic EMG GG , and nadir P EPI are back-transformed values. improvements in ventilation 3, 12, 14, 15, 17, 19 and resistance 10, [17] [18] [19] postarousal. Therefore, obstructive event termination, despite associated arousal, may have a stabilizing effect upon the upper airway that persists for at least a few breaths following the resumption of sleep. Indeed, that dilator muscle activity and upper airway patency were improved despite hypocapnia suggests that conventional respiratory control is not operating as expected immediately following arousal. We theorize that this may be attributable to an after-discharge effect that overrides hypocapnia. The stimulus responsible for eliciting the after-discharge is unclear. Likely candidates are airway opening, arousal, or a combination of both. Indeed, large bursts of dilator muscle activity followed by a slow decay have been demonstrated following event termination without clear arousal 3 as well as instances of arousal where the airway is patent. 11, 12 Younes and colleagues recently demonstrated genioglossus after-discharge in patients with OSA following obstructive events induced with short, three breath CPAP dial-downs. 15 Genioglossus after-discharge was shorter in duration for dial-downs was associated with arousal (~30 seconds) compared to those without arousal (at least ~60 seconds), suggesting that airway opening is the stimulus likely responsible for eliciting after-discharge.
Associations Between End-Arousal ∆CO 2, Genioglossus Activity, and Ventilation Following the Return to Sleep
Genioglossus activity A negative end-arousal ∆CO 2 (below wakefulness) was associated with elevated ventilation and genioglossus activity on the last arousal breath. This was unsurprising as large arousal responses likely result in greater hypocapnia. Nevertheless, following the resumption of sleep, it would be expected that conventional respiratory control be reestablished. However, this negative association continued following the return to sleep. That genioglossus muscle activity was higher following the return to sleep for the arousals associated with a negative end-arousal ∆CO 2 may be explained by the after-discharge decay starting from a higher level of genioglossus activation (i.e., larger ventilatory and dilator activation at arousal, result in more pronounced hypocapnia and a higher starting point for after-discharge).
These findings are discrepant with a study that demonstrated reduced genioglossus activity following hypocapnia induced during stable sleep in individuals with mild anatomical compromise. 9 The discrepancy may be because stable sleep is unlikely to feature abrupt increases in genioglossus activity and therefore, after-discharge would not occur, enabling the adverse effects of hypocapnia. Alternatively, the duration of hypocapnia may be influential. For instance, the current study assessed transient hypocapnia elicited by arousal, whereas the earlier study assessed longer duration hypocapnia elicited by continuous hypoxia.
Ventilation and Negative Pressure at the Epiglottis
The relationship between ventilation and end-arousal ∆CO 2 varied following the return to sleep such that by the third breath, negative end-arousal ∆CO 2 was associated with low-level ventilation. Thus, for ventilation, conventional respiratory control was reestablished. In addition, a negative end-arousal ∆CO 2 was associated with less negative epiglottic pressures (closer to zero) following the return to sleep. The reduced epiglottic pressure may be the result of reduced respiratory drive secondary to hypocapnia. This interpretation is consistent with the study of tracheostomized patients with OSA, which found both ventilation and respiratory drive (measured by expiratory pause duration) proportionally decreased following arousal with reduced CO 2.
28 However, this interpretation of the current study must be met with caution as the reduction in negative epiglottic pressure may also be secondary to improved airway caliber. As upper airway resistance was not measured, determining which of these processes were responsible was not possible.
Implications
This study demonstrated that arousal-induced hypocapnia does not reduce dilator muscle activity. It is possible that the dilator muscle after-discharge elicited at obstructive event termination may be beneficial for upper airway patency, despite the occurrence of arousal and associated hypocapnia. Indeed, secondary obstructive events have improved dilator muscle activity and flow compared to proceeding obstructive events, despite arousal. 1, 3 Furthermore, genioglossus activity has been shown to progressively ramp up during sleep periods associated with respiratory events and in some patients with OSA results in stable breathing during sleep. 21 This ramping up of genioglossus activity may be attributed to an after-discharge that follows obstructive event termination. Whether this is the case is unclear. However, that muscle activity can be elevated, despite hypocapnia and reduced negative pressure suggests that after-discharge is worth exploring further. Future studies should determine which stimuli are best for eliciting after-discharge and whether they can be utilized to improve OSA treatment. For instance, after-discharge enhancement may improve the efficacy of hypoglossal nerve stimulation treatment. However, even if after-discharge associated with arousal is beneficial for genioglossus activity, there are still elements of arousal that are likely detrimental to OSA. For instance, arousal may destabilize respiratory control and result in a waxing and waning of ventilation. Or, arousal may reduce the likelihood of stable breathing during sleep by preventing entry into deeper sleep.
Limitations
Our study has several limitations. First, P ET CO 2 was measured on the last arousal breath, as we believed this breath captured the full extent of hypocapnia. P ET CO 2 was not measured during obstruction, as expiratory volume did not provide an adequate end-tidal sample. Second, the predicted NREM CO 2 set point was estimated from healthy individuals as patients with OSA do not often experience stable breathing. However, a subanalysis of the patients with OSA who did achieve stable breathing (n = 13) demonstrated that the predicted NREM CO 2 set point was an accurate estimation (3 mm Hg above wakefulness). Third, upper airway resistance was not assessed. This is because resistance is measured prior to flow limitation and cannot be measured during apnea. Therefore, resistance measurements would have produced a large amount of missing data. Fourth, the genioglossus muscle was measured, as it is critical to upper airway patency and is easily accessible by needle electrodes. However, other dilator muscles may respond differently. Fifth, it is possible that the elevated genioglossus activity is not attributable to after-discharge but rather persistent hypercapnia present at the central chemoreceptors. In this scenario, the hypocapnia observed at end-arousal may not have reached the chemoreceptors due to the circulatory delay. However, this is unlikely as ventilation showed responses consistent with reduced respiratory drive. Sixth, mixed apneas were not assessed, as they were infrequent and cannot be easily interpreted breath by breath. The postarousal dilator activity may differ for these event types. For instance, CO 2 may be the primary stimulus driving these events due to the apneic threshold being met or due to a failure of the after-discharge mechanism. Finally, events terminating without arousal were not analyzed because the primary objective was to assess the influence of arousal-induced hypocapnia on dilator muscle activity. Therefore, it was considered necessary to analyze P ET CO 2 at end-arousal and genioglossus activity immediately following the return to sleep. Events associated with and without arousal could be compared by lining up both types of events relative to the breath of airway opening or the resumption of apnea/hypopnea. However, this analysis would be biased as events without arousal are generally less severe and associated with less marked hyperventilation, thus limiting the range of CO 2 changes observed.
CONCLUSION
Arousal-induced hypocapnia does not predispose to further collapse in OSA via reduced dilator muscle activity. Rather genioglossus activity was increased following the return to sleep, relative to prearousal levels, and this increase was greatest when end-arousal CO 2 was most reduced below wakefulness. This increased genioglossus activity was likely attributable to after-discharge elicited by a large dilator muscle response to airway opening and or arousal. Future studies should aim to understand the mechanisms underlying dilator muscle after-discharge. If dilator muscle after-discharge is beneficial for upper airway patency, it may offer a potential treatment target.
